Clin2
NCT07187466Possibly a fitNot yet recruiting

Behavioral therapy and a drug for bladder problems in Parkinson disease

Overactive BladderParkinson Disease

Treatments studied

Part of Brain & nervous system, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether behavioral therapy (like bladder training and pelvic floor exercises) alone, or combined with a medication called mirabegron, is better at improving bladder symptoms (like sudden urges and frequent urination) in people with Parkinson's disease. The goal is to see which approach helps reduce urgency and improve daily life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
146 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a diagnosis of Parkinson's disease confirmed by a neurologist.
  • You have bothersome bladder symptoms like sudden urges to urinate, going often, or waking at night.
  • You do not have significant memory or thinking problems (like dementia).
  • You have not had intensive pelvic floor muscle training in the past.
  • You do not have severe depression that could hinder your participation.
  • You are not using a urinary catheter or have a history of severe urinary retention.
  • You have not had certain bladder surgeries or Botox in the bladder recently.
  • Your diabetes, if you have it, is well-controlled and you are not on dialysis.
  • You are not currently being treated for certain cancers or have unstable health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05362292Recruiting· Phase 4
Treating bladder leakage to support mind and body health

This study tests medicines to reduce “urgency” urine leakage (when you suddenly feel you must go) and to see whether improving bladder control also helps overall mental and physical health. You may be eligible if you have had these symptoms for at least 3 months and can follow the study plan.

Palo Alto, California
NCT06662565Not yet recruiting
Pelvic floor relaxation for overactive bladder in women

This study tests a pelvic floor muscle relaxation technique (called 'down-training') to see if it helps women with overactive bladder. It may be a good fit if you have both constipation and tight pelvic floor muscles.

Cairo
NCT06754553Not yet recruiting
Pimavanserin for impulse control issues in Parkinson's disease

This study tests a medication called pimavanserin to see if it helps reduce impulse control problems (like compulsive gambling or eating) in people with Parkinson's disease. If you struggle with these behaviors, this treatment might bring relief.

Besançon
NCT07627529Not yet recruiting· Phase 4
Reducing bladder medication in Parkinson's disease

This study tests whether gradually reducing or stopping certain bladder medications (called antimuscarinics) can improve symptoms in people with Parkinson's disease. If you qualify, you might get a different bladder medication (like mirabegron) as part of the study.

Philadelphia, Pennsylvania
NCT07744620Not yet recruiting
Comparing treatments for overactive bladder

This study compares three ways to help people with overactive bladder: learning about the condition, using biofeedback to train your pelvic muscles, and using nerve stimulation. It aims to find which approach works best to reduce urgent, frequent urination.

New Taipei City, Taiwan
NCT07719400Not yet recruiting
Pelvic floor and bladder training for men with urinary frequency

This study tests whether combining pelvic floor muscle exercises with bladder training can help reduce how often men need to urinate. It aims to improve bladder control and reduce the number of bathroom trips.

Hear when a new Overactive Bladder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.